Recherche Fr menu ClientConnect
Recherche
Résultats
5 premiers résultats de la recherche Voir tous les résultats Recherche avancée
Recherches les plus fréquentes
Pages les plus visitées
    Référence: 20200592
    Date de publication: 3 mai 2021

    Promoteur – Intermédiaire Financier

    DRAEGERWERK AG & CO KGAA

    Lieu

    Description

    The project concerns the Promoter's corporate research and development (R&D) programme in its medical division for the period 2021-2023, with a particular focus on connected health devices.

    Objectifs

    The project's emphasis on connected health devices follows the trend of therapy automation in hospitals through diagnostic and therapeutic assistance systems. Since the outbreak of COVID-19, the relevance and demand for connected health devices has significantly increased.

    Secteur(s)

    Montant BEI envisagé (montant approximatif)

    EUR 100 million

    Coût total (montant approximatif)

    EUR 225 million

    Aspects environnementaux

    The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) 2014/52/EU amending the EIA Directive 2011/92/EC. Full environmental details will be verified during the appraisal.

    Passation des marchés

    The Promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.

    Statut

    Signé - 14/04/2021

    Mots-clés correspondants

    Allemagne Industrie